Lung Transplantation in Interstitial Lung Disease

Kim, Cynthia; Cordova, Francis; Toyoda, Yoshiya

doi:10.1007/978-3-319-49918-5_5

Cited by 1 publication

(2 citation statements)

References 86 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to the ISHLT registry, ILDs made up almost 21% of the LTx performed from 1995 to 2018 [ 11 ]. Even though there is a tendency for BLT, studies have failed to show its superiority over SLT in terms of survival [ 95 , 96 ]. Another issue is the extrapulmonary involvement of ILDs due to connective tissue disorders (CTD) which may complicate the LTx procedure.…”

Section: Interstitial Lung Diseasesmentioning

confidence: 99%

See 1 more Smart Citation

Recurrence of primary disease following lung transplantation

et al. 2022

View full text Add to dashboard Cite

Lung transplant has become definitive treatment for patients with several end-stage lung diseases. Since the first attempted lung transplantation in 1963, survival has significantly improved due to advancement in immunosuppression, organ procurement, ex-vivo lung perfusion, surgical techniques, prevention of chronic lung allograft dysfunction, and bridging to transplant using extra-corporeal membrane oxygenation. Despite a steady increase in number of lung transplantations each year, there is still a huge gap between demand and supply of organs available, and work continues to select recipients with potential for best outcomes. According to review of the literature, there are some rare primary diseases that may recur following transplantation. As the number of lung transplants increase, we continue to identify disease processes at highest risk for recurrence, thus shaping our future approaches. While the aim of lung transplantation is improving survival and quality of life, choosing the best recipients is crucial due to shortage of donated organs. Here we discuss the common disease processes that recur and highlight its impact on overall outcome following lung transplantation.

show abstract

Section: Interstitial Lung Diseasesmentioning

confidence: 99%

“…The most common ILD-associated CTDs are scleroderma (61%), rheumatoid arthritis (13%) and polymyositis/dermatomyositis (12%) [ 96 ]. Hypersensitivity pneumonitis is another type of ILD caused by inhalation of a specific antigen which can be identified in almost 40% of the cases [ 97 ].…”

Section: Interstitial Lung Diseasesmentioning

confidence: 99%